In a report released yesterday, Alex Arfaei from BMO Capital assigned a Sell rating to AbbVie (NYSE: ABBV), with a price target of $78. The company’s shares closed yesterday at $106.23.
According to TipRanks.com, Arfaei is a 4-star analyst with an average return of 4.7% and a 65.3% success rate. Arfaei covers the Healthcare sector, focusing on stocks such as Merck & Company, Eli Lilly & Co, and Bristol Myers.
AbbVie has an analyst consensus of Moderate Buy, with a price target consensus of $119.86.
See today’s analyst top recommended stocks >>
AbbVie’s market cap is currently $168.6B and has a P/E ratio of 26.76. The company has a Price to Book ratio of 47.44.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ABBV:
